BMS Makes Dealmaking A Top Priority As Doubts About Growth Increase

Observers Fear New Drugs Will Not Fill LOE Gap

 
• By Mandy Jackson
  
Growth is top of mind for BMS as LOEs approach later this decade (Shutterstock)

More from Earnings

More from Scrip